Hikma Pharmaceuticals Plc Holding(s) in Company (3666S)
20 December 2016 - 10:00PM
UK Regulatory
TIDMHIK
RNS Number : 3666S
Hikma Pharmaceuticals Plc
20 December 2016
For filings with the FCA
include the annex
For filings with issuer exclude
the annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
---------------------------------------------------------------------------------------------------
1. Identity of the issuer or Hikma Pharmaceuticals PLC
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
------------------------------------------------------ -------------------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
---------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
------------------------------------------------------------------------------------------ -------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
------------------------------------------------------------------------------------------ -------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
------------------------------------------------------------------------------------------ -------
An event changing the breakdown of voting rights
------------------------------------------------------------------------------------------ -------
Other (please New issued share capital affected ü
specify): existing holding percentage
----------------------------------------------------- ----------------------------------- -------
3. Full name of person(s) Darhold Limited
subject to the
notification obligation:
(iii)
------------------------------------------------------ -------------------------------------------
4. Full name of shareholder(s) Darhold Limited
(if different from 3.):(iv)
------------------------------------------------------ -------------------------------------------
5. Date of the transaction 19 December 2016
and date on
which the threshold is
crossed or
reached: (v)
------------------------------------------------------ -------------------------------------------
6. Date on which issuer 19 December 2016
notified:
------------------------------------------------------ -------------------------------------------
7. Threshold(s) that is/are
crossed or
reached: (vi, vii) 25%
------------------------------------------------------ -------------------------------------------
8. Notified details:
----------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
----------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
-------------- ---------------------------------- ------------------------------------------------------------------
Number Number Number Number of % of voting
of of of shares voting rights (x)
Shares Voting rights
Rights
-------------- ---------------- ---------------- -------------- --------------------------- ---------------------
Indirect Direct Indirect Direct Indirect
(xi) (xii)
-------------- ------------ ------------ -------------- ------------- ------------ -------- -----------
GB00B0LCW083 60,000,000 60,000,000 0 25.00% 0
-------------- ------------- ------------ -------- -----------
59,909,270 59,909,270
-------------- ---------------- ---------------- ------------ ----------- ------------ -------- ---------
B: Qualifying Financial Instruments
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date Conversion rights that rights
(xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
------------------ -------------- -------------------------------- ------------------------- ---------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights (xix,
instrument (xvii) period refers to xx)
(xviii)
---------------- -------------- -------------- -------------- ----------------------------- ---------------------
Nominal Delta
---------------- -------------- -------------- -------------- ----------------------------- ---------- ---------
Total (A+B+C)
----------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
---------------------------------------------------------------- ----------------------------------------------------
60,000,000 25.00%
---------------------------------------------------------------- ----------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
----------------------------------------------------------------------------------------------------------------------
N/A
Proxy Voting:
----------------------------------------------------------------------------------------------------------------------
10. Name of the proxy holder: N/A
--------------------------------------------------------------------------------- -----------------------------------
11. Number of voting rights proxy holder
will acquire: 0
--------------------------------------------------------------------------------- -----------------------------------
12. Date on which proxy holder will N/A
acquire voting rights:
--------------------------------------------------------------------------------- -----------------------------------
13. Additional information:
---------------------------------------------------------------- ----------------------------------------------------
14. Contact name: Peter Speirs, Company Secretary
of Hikma Pharmaceuticals
PLC
---------------------------------------------------------------- ----------------------------------------------------
15. Contact telephone number: +44 207 399 2772
---------------------------------------------------------------- ----------------------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLURVRRNNAUUAA
(END) Dow Jones Newswires
December 20, 2016 06:00 ET (11:00 GMT)
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Apr 2024 to May 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From May 2023 to May 2024
